Staff Members - Benha University
The significance of Aldehyde dehydrogenase 1A1 expression in benign prostatic hyperplasia, prostatic intraepithelial neoplasia and prostatic adenocarcinoma
• 2019
Publication Information
Authors
Sara Gamal Abd El-moez Masoud, Magda Hamed Bakr, . Nashwa Mohamed Emara, Sarah Nabil Nasif.
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: Prostate cancer (PCa) contains a small population of cancer stem cells (CSCs) that promote tumor growth, maintenance, and progression. Therefore, CSC markers could provide a prognostic strategy for human malignancies. This study aimed to evaluate the expression patterns and clinical significance of stem cell marker aldehyde dehydrogenase 1A1 (ALDH1A1) in prostatic tissues.
Methods: This is a retrospective study performed upon 60 cases designated as; 10 cases (16.7%) of benign prostatic hyperplasia (BPH), 6 cases (10%) of high-grade prostatic intraepithelial neoplasia (HGPIN) and 44 cases (73.3%) of prostatic adenocarcinoma (PCa) of different Gleason scores. Immunohistochemistry was applied on formalin-fixed, paraffin-embedded tissue blocks using ALDH1A1. Clinicopathological data were reviewed from patients' pathological reports and the relation between ALDH1A1 expression and clinicopathologic parameters was assessed.
Results: Low expression of ALDH1A1 was seen in 10/10 (100%) of BPH cases, 5/6 (83.3%) of HGPIN and 12/44 (27.3%) of PCa, while high expression was in 1/6 case (16.7%) of HGPIN and 32/44 (72.2%) of PCa cases. There was a significant difference between the expression level of ALDH1A1 in PCa compared with HGPIN and BPH cases (P
Methods: This is a retrospective study performed upon 60 cases designated as; 10 cases (16.7%) of benign prostatic hyperplasia (BPH), 6 cases (10%) of high-grade prostatic intraepithelial neoplasia (HGPIN) and 44 cases (73.3%) of prostatic adenocarcinoma (PCa) of different Gleason scores. Immunohistochemistry was applied on formalin-fixed, paraffin-embedded tissue blocks using ALDH1A1. Clinicopathological data were reviewed from patients' pathological reports and the relation between ALDH1A1 expression and clinicopathologic parameters was assessed.
Results: Low expression of ALDH1A1 was seen in 10/10 (100%) of BPH cases, 5/6 (83.3%) of HGPIN and 12/44 (27.3%) of PCa, while high expression was in 1/6 case (16.7%) of HGPIN and 32/44 (72.2%) of PCa cases. There was a significant difference between the expression level of ALDH1A1 in PCa compared with HGPIN and BPH cases (P